NEW YORK (GenomeWeb News) – The DNA Medicine Institute has won a Small Business Innovation Research contract worth $600,000 over two years from the National Aeronautics and Space Administration to develop nanoscale diagnostic assays for analyzing health from blood samples.

The for-profit firm, which bases its products on nanotechnology, genomics, and molecular biology among others, will use the Phase II funding to develop assays for assessment of bone loss, immune function, cardiac health, liver function, and lipid status.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.